Bonus Biogroup Ltd.
Total Valuation
ILAAs of June 30, 2025, Bonus Biogroup Ltd. carries a market capitalization of 23.71B, placing it among publicly traded companies globally. Its enterprise value stands at 24.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 23.71B |
| Enterprise Value | 24.55B |
Share Statistics
As of June 30, 2025, Bonus Biogroup Ltd. has 1.17B shares outstanding.
| Shares Outstanding | 1.17B |
Valuation Ratios
These figures are as of June 30, 2025.
| PB Ratio | -141.55 |
| P/TBV Ratio | -141.55 |
Financial Position
As of June 30, 2025, Bonus Biogroup Ltd. maintains a current ratio of 0.21, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.21 |
| Quick Ratio | 0.11 |
| Debt / Equity | -573.31 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2025.
| Employee Count | 53.50 |
Stock Price Statistics
ILAAs of the close on October 22, 2026, Bonus Biogroup Ltd.'s stock has declined approximately 18.18% over the past 52 weeks. The 50-day moving average sits at 19.02, while the 200-day moving average is 33.75.
| 52-Week Price Change | -18.18% |
| 50-Day Moving Average | 19.02 |
| 200-Day Moving Average | 33.75 |
Balance Sheet
ILAAs of June 30, 2025, Bonus Biogroup Ltd. holds 119.70M in cash and equivalents against 960.30M in total debt, resulting in a net debt position of -119.70M. Total book value stands at -167.50M, with working capital of -878.40M providing operational flexibility.
| Cash & Cash Equivalents | 119.70M |
| Total Debt | 960.30M |
| Net Debt | -119.70M |
| Equity (Book Value) | -167.50M |
| Book Value Per Share | -0.14 |
| Working Capital | -878.40M |
Cash Flow
ILAThese figures cover the twelve months ended June 30, 2025.
| Capital Expenditures | -16.10M |
Stock Splits
Bonus Biogroup Ltd.'s most recent stock split took place on June 3, 2012 with a 10:1 split ratio.
| Last Split Date | 6/3/2012 |
| Split Ratio | 10:1 |